ZK 90055
Latest Information Update: 14 Nov 1994
At a glance
- Originator Schering-Plough
- Class Antiallergics; Antiasthmatics
- Mechanism of Action Beta 2 adrenergic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma